LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR EBITDA Margin
EBITDA as a percentage of revenue.
LENSAR, Inc.NASDAQ: LNSR
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to 279.0%
EBITDA Margin was 279.0% in Q1 FY2026, up 464.5 pp from a year earlier. On a trailing-twelve-month basis it was 58.8%, up 150.4 pp year over year. Over 3 fiscal years it narrowed by 4.3 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 3 analysts of 3.7% for the fiscal year ending Dec 2026, up from -51.0% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 279.0%+280.8 pp QoQ
- Last fiscal yearDec 2025
- -51.0%-45.3 pp YoY
- LTMMar 2026
- 58.8%+150.4 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +464.5 pp | -1.6 pp | -466.1 pp |
| 1 year | -45.3 pp | +54.7 pp | +100.0 pp |
| 3 years | -4.3 pp | +56.9 pp | +61.1 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -51.0%
- Year-over-year change
- -45.3pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -51.0% | -45.3pp |
| FY2024 | 2024-12-31 | -5.6% | +20.2pp |
| FY2023 | 2023-12-31 | -25.8% | +20.9pp |
| FY2022 | 2022-12-31 | -46.7% | +2.2pp |
| FY2021 | 2021-12-31 | -48.9% | — |
EBITDA Margin vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 EBITDA Margin of 58.8% is the highest of the 9 companies compared; the peer median is -119.3%.
- Its year-over-year change of +150.4 pp is the highest of 9, against a peer median of -6.7 pp.
- Over three fiscal years its change of -4.3 pp compares with a peer median of +110.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 58.8% | +150.4 pp | -4.3 pp | |
| LTM Mar 2026 | -4.0% | -3.6 pp | -19.7 pp | |
| LTM Mar 2026 | -40.4% | -29.4 pp | +75.4 pp | |
| LTM Mar 2026 | -46.7% | +22.3 pp | +304.0 pp | |
| LTM Mar 2026 | -107.3% | -9.8 pp | -72.7 pp | |
| LTM Mar 2026 | -131.2% | +8.9 pp | +214.5 pp | |
| LTM Mar 2026 | -200.6% | +96.6 pp | +145.4 pp | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | -5021.0% | -1760.3 pp | -3924.4 pp |
| LTM Mar 2026 | -8329.5% | -111.2 pp | +2386.2 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding LNSR) | -119.3% | -6.7 pp | +110.4 pp | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 34.46M | 35.36M | 42.16M | 53.49M | 58.44M |
| Cost of Revenue | 16.63M | 15.4M | 21.06M | 27.64M | 31.31M |
| Gross Profit | 17.83M | 19.96M | 21.11M | 25.85M | 27.12M |
| Gross Margin | 51.8% | 56.4% | 50.1% | 48.3% | 46.4% |
| Research & Development | 12.36M | 11.81M | 6.14M | 5.33M | 5.62M |
| Selling, General & Admin | 23.89M | 27.17M | 26.1M | 26.49M | 45.16M |
| Operating Expenses | 37.49M | 40.13M | 33.34M | 36.52M | 51.7M |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| EBITDA | (16.84M) | (16.51M) | (10.87M) | (3.01M) | (29.78M) |
| EBITDA Margin | -48.9% | -46.7% | -25.8% | -5.6% | -51.0% |
| Operating Income | (19.65M) | (20.18M) | (12.23M) | (10.67M) | (24.58M) |
| Operating Margin | -57.0% | -57.1% | -29.0% | -19.9% | -42.1% |
| Interest Income | 34K | 17K | 85K | 103K | 91K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 51K | 263K | (2.15M) | (20.74M) | (9.7M) |
| Income Before Tax | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Pre-Tax Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Net Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| EPS (Basic) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| EPS (Diluted) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| Weighted Avg Shares | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
| Weighted Avg Shares (Diluted) | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.